Search | IOVS | ARVO Journals

Showing 1 – 20 of 60

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Geographic Atrophy in Eyes with Neovascular Age-related Macular Degeneration (nAMD) Treated with Anti-VEGF Compared to Untreated Fellow Eyes without nAMD

Erik Nicholas Grobben; Maureen Maguire; Ebenezer Daniel; Maxwell Pistilli; Gui-Shuang Ying; Juan E Grunwald; E Revel Martin

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3504. doi:

ARVO Annual Meeting Abstract July 2019

Incidence and Features of Geographic Atrophy in Fellow Eyes in the Comparison of Age-related Macular Degeneration Treatment Trials (CATT)

Delu Song; Gui-Shuang Ying; Juan E Grunwald; Ebenezer Daniel; Maureen G Maguire; Yafeng Li; Daniel F Martin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1144. doi:

ARVO Annual Meeting Abstract July 2018

Association between Oral Iron Supplementation and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials

Delu Song; Gui-Shuang Ying; Joshua L Dunaief; Rupak Bhuyan; Yafeng Li; Maureen G. Maguire; Juan E Grunwald; Ebenezer Daniel; Stephanie A Hagstrom; Daniel F Martin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2396. doi:

ARVO Annual Meeting Abstract July 2018

Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Benjamin J Kim; Wei Pan; Juan E Grunwald; Gui-Shuang Ying; Cynthia A Toth; Glenn J Jaffe; Daniel F Martin; Maureen G. Maguire

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3252. doi:

ARVO Annual Meeting Abstract June 2017

Characteristics of Patients with Good Visual Acuity at 5 Years Despite No Treatment after 2 Years in the Comparison of AMD Treatment Trials (CATT) Follow-up Study

Daniel F Martin; Stuart L Fine; Wei Pan; Juan E Grunwald; Ebenezer Daniel; Glenn J Jaffe; Cynthia A Toth; Gui-Shuang Ying; Maureen G Maguire

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1196. doi:

ARVO Annual Meeting Abstract June 2017

Distribution of optical coherence tomographic morphologic components within areas appearing as atrophic or scarred after two years of anti-VEGF treatment for neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Cynthia A Toth; Vincent Tai; Maxwell Pistilli; Stephanie Chiu; Katrina Winter; Ebenezer Daniel; Juan E Grunwald; Glenn J Jaffe; Daniel F Martin; Gui-Shuang Ying; Sina Farsiu; Maureen G Maguire

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1195. doi:

ARVO Annual Meeting Abstract June 2017

Incidence and risk factors for neovascular AMD in the fellow eye in the Comparison of AMD Treatment Trials (CATT) Follow-up Study

Maureen G Maguire; Wei Pan; Juan E Grunwald; Ebenezer Daniel; Glenn Jay Jaffe; Cynthia A Toth; Stephanie A Hagstrom; Gui-Shuang Ying; Daniel F Martin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2323. doi:

ARVO Annual Meeting Abstract June 2017

Risk factors for retinal scar development in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Juan E Grunwald; Maureen G Maguire; Wei Pan; Cynthia A Toth; Glenn Jay Jaffe; Daniel F Martin; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2337. doi:

ARVO Annual Meeting Abstract June 2017

Linking optical coherence tomographic, angiographic and photographic lesion components in neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Vincent Tai; Stephanie Chiu; Katrina Winter; Ebenezer Daniel; Juan E Grunwald; Maxwell Pistilli; Monica Sevilla; Gui-Shuang Ying; Glenn J Jaffe; Daniel F Martin; Sina Farsiu; Maureen G Maguire; Cynthia A Toth

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):870. doi:

ARVO Annual Meeting Abstract June 2017

Baseline Predictors of Five-Year Visual Acuity in the Comparison of AMD Treatment Trials (CATT)

Gui-Shuang Ying; Maureen G Maguire; Wei Pan; Juan E Grunwald; Ebenezer Daniel; Glenn J Jaffe; Cynthia A Toth; Daniel F Martin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):886. doi:

ARVO Annual Meeting Abstract September 2016

Size and Growth of Geographic Atrophy During 5 Years of Follow Up in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Juan E Grunwald; Maxwell Pistilli; Ebenezer Daniel; Gui-Shuang Ying; Glenn J Jaffe; Stuart L Fine; Daniel F Martin; Maureen G Maguire

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Pseudodrusen and Incidence of Late Age-related Macular Degeneration (AMD) in Fellow Eyes in the Comparison of AMD Treatments Trials (CATT)

Qiang Zhou; Ebenezer Daniel; Maureen G Maguire; Juan E Grunwald; Revell Martin; Daniel F Martin; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Juan E Grunwald; Benjamin J Kim; Maureen G Maguire; James A Shaffer; Glenn J Jaffe; Cynthia A Toth; Daniel F Martin; Frederick L Ferris; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2653. doi:

ARVO Annual Meeting Abstract June 2015

Retinal Angiomatous Proliferation and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Maureen G Maguire; James Shaffer; Gui-Shuang Ying; Juan E Grunwald; Glenn J Jaffe; Daniel F Martin; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2833. doi:

ARVO Annual Meeting Abstract June 2015

Petaloid Macular Edema and Outcomes in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Neepa Shah; Maureen G Maguire; Daniel F Martin; James Shaffer; Gui-Shuang Ying; Juan E Grunwald; Cynthia A Toth; Glenn J Jaffe; Ebenezer Daniel; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2847. doi:

ARVO Annual Meeting Abstract June 2015

Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of AMD Treatments Trials (CATT)

Thomas A Ciulla; Gui-Shuang Ying; Maureen G Maguire; Daniel F Martin; Glenn J Jaffe; Juan E Grunwald; Ebenezer Daniel; Cynthia A Toth; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3154. doi:

ARVO Annual Meeting Abstract June 2015

Association between Antiplatelet or Anticoagulant Drugs and Retinal Hemorrhage in the Comparison of AMD Treatments Trials (CATT)

Gui-Shuang Ying; Maureen G Maguire; Ebenezer Daniel; Juan E Grunwald; Daniel F Martin; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2569. doi:

ARVO Annual Meeting Abstract April 2014

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Sumit Sharma; Cynthia A Toth; Ebenezer Daniel; Juan E Grunwald; Maureen G Maguire; Gui-Shuang Ying; Daniel F Martin; Glenn J Jaffe; Comparison of Age-related Macular Degeneration Treatment Trials (CATT) Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1311. doi:

ARVO Annual Meeting Abstract April 2014

Size and growth of geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Juan E Grunwald; Maxwell Pistilli; Ebenezer Daniel; Gui-Shuang Ying; Stuart L Fine; Daniel F Martin; Maureen G Maguire; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1649. doi:

ARVO Annual Meeting Abstract April 2014

Delayed Patchy Choroidal Filling in the Comparison of Age-related Macular Degeneration Treatment Trials (CATT)

Dina Gewaily; Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Maureen G Maguire; Ebenezer Daniel; Candace P Ostroff; Stuart L Fine

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4934. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Geographic Atrophy in Eyes with Neovascular Age-related Macular Degeneration (nAMD) Treated with Anti-VEGF Compared to Untreated Fellow Eyes without nAMD

Incidence and Features of Geographic Atrophy in Fellow Eyes in the Comparison of Age-related Macular Degeneration Treatment Trials (CATT)

Association between Oral Iron Supplementation and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials

Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Characteristics of Patients with Good Visual Acuity at 5 Years Despite No Treatment after 2 Years in the Comparison of AMD Treatment Trials (CATT) Follow-up Study

Distribution of optical coherence tomographic morphologic components within areas appearing as atrophic or scarred after two years of anti-VEGF treatment for neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Incidence and risk factors for neovascular AMD in the fellow eye in the Comparison of AMD Treatment Trials (CATT) Follow-up Study

Risk factors for retinal scar development in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Linking optical coherence tomographic, angiographic and photographic lesion components in neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Baseline Predictors of Five-Year Visual Acuity in the Comparison of AMD Treatment Trials (CATT)

Size and Growth of Geographic Atrophy During 5 Years of Follow Up in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Pseudodrusen and Incidence of Late Age-related Macular Degeneration (AMD) in Fellow Eyes in the Comparison of AMD Treatments Trials (CATT)

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Retinal Angiomatous Proliferation and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Petaloid Macular Edema and Outcomes in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of AMD Treatments Trials (CATT)

Association between Antiplatelet or Anticoagulant Drugs and Retinal Hemorrhage in the Comparison of AMD Treatments Trials (CATT)

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Size and growth of geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Delayed Patchy Choroidal Filling in the Comparison of Age-related Macular Degeneration Treatment Trials (CATT)

To View More...

You must be signed into an individual account to use this feature.